» Articles » PMID: 34061564

Disparities in Pediatric Oncology: The 21st Century Opportunity to Improve Outcomes for Children and Adolescents With Cancer

Overview
Specialty Oncology
Date 2021 Jun 1
PMID 34061564
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Adult cancer disparities have been documented for decades and continue to persist despite clinical advancements in cancer prevention, detection, and treatment. Pediatric cancer survival has improved significantly in the United States for the past 5 decades to over 80%; however, disparate outcomes among children and adolescents with cancer still affect many populations in the United States and globally, including racial and ethnic minorities, populations with low socioeconomic status, and residents of underserved areas. To achieve equitable outcomes for all children and adolescents with cancer, it is imperative that concerted multilevel approaches be carried out to understand and address health disparities and to ensure access to high-quality cancer care. Addressing social determinants of health, such as removing barriers to health care access and ensuring access to social supports, can reduce pediatric cancer disparities. Nevertheless, public health policy, health system interventions, and innovative delivery of evidence-based services are critically needed. Partnerships among patients, caregivers, and health care providers, and among health care, academic, and governmental institutions, have a pivotal role in reducing cancer disparities and improving outcomes in the 21st century.

Citing Articles

Central venous access device management for children undergoing treatment for blood disorders and cancer: a descriptive international cross-sectional survey.

Hyun A, Takashima M, de Souza S, Gibson V, Silva T, Rocha P Support Care Cancer. 2025; 33(3):179.

PMID: 39937270 PMC: 11821666. DOI: 10.1007/s00520-025-09240-z.


Pediatric and adolescent cancer disparities in the Middle East and North Africa (MENA) region: incidence, mortality, and survival across socioeconomic strata.

Shukla A, Zeidan R, Saddik B BMC Public Health. 2024; 24(1):3602.

PMID: 39736554 PMC: 11684239. DOI: 10.1186/s12889-024-21155-8.


Increased Early-Mortality in Children With Solid Tumors During the COVID-19 Pandemic in a Middle-Income Country.

Ramirez O, Piedrahita V, Bolivar S, Grillo K, Linares A, Pardo C Cancer Med. 2024; 13(24):e70483.

PMID: 39711262 PMC: 11803909. DOI: 10.1002/cam4.70483.


Patient participation in clinical trials conducted by principal investigators who speak one or more language(s) beyond english: Exploring ethnicity as proxy for language.

Rivelli A, Ozoani-Lohrer O, Lefaiver C, Shields M, Marek A, Robaina M Contemp Clin Trials Commun. 2024; 41:101353.

PMID: 39252860 PMC: 11382018. DOI: 10.1016/j.conctc.2024.101353.


Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials.

Shoag J, Li Y, Getz K, Huang Y, Hall M, Naranjo A Pediatr Blood Cancer. 2024; 71(10):e31192.

PMID: 38997807 PMC: 11343658. DOI: 10.1002/pbc.31192.


References
1.
Aristizabal P, Singer J, Cooper R, Wells K, Nodora J, Milburn M . Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities. Pediatr Blood Cancer. 2015; 62(8):1337-44. PMC: 4482802. DOI: 10.1002/pbc.25472. View

2.
Bona K, Blonquist T, Neuberg D, Silverman L, Wolfe J . Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010). Pediatr Blood Cancer. 2016; 63(6):1012-8. DOI: 10.1002/pbc.25928. View

3.
Metzger M, Castellino S, Hudson M, Rai S, Kaste S, Krasin M . Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma. J Clin Oncol. 2008; 26(8):1282-8. DOI: 10.1200/JCO.2007.14.0699. View

4.
Scheurer M, Lupo P, Schuz J, Spector L, Wiemels J, Aplenc R . An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018; 35(2):95-110. PMC: 6685736. DOI: 10.1080/08880018.2018.1464088. View

5.
Pollock B, DeBaun M, Camitta B, Shuster J, Ravindranath Y, Pullen D . Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol. 2000; 18(4):813-23. DOI: 10.1200/JCO.2000.18.4.813. View